Can a smartphone app make surgeons seem more empathetic?
NCT ID NCT04688762
First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time
Summary
This trial tests a digital application designed to help surgeons explain breast cancer surgery to patients. The goal is to see if using the app during the first consultation makes patients feel their doctor is more empathetic and empowers them in decision-making. The study involves women scheduled for a lumpectomy and sentinel node biopsy.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- e-consult application (digital tool)
- What this could lead to
- If effective, this app could become a simple way to help patients feel more understood and involved in their surgical care.
- What could go wrong
- This is a small, early-stage study focused on patient perception, not medical outcomes. The app may not change actual empathy or satisfaction.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
207 people
The number who actually took part.
- Started
-
Dec 2020
- Finished
-
Nov 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patient with breast cancer with surgery indication
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient \> 18 years old * Patient referred for first consultation for surgery * Patient referred for a breast tumorectomy and axillary sentinel node * No patient opposition to participating in this study Exclusion Criteria: * Non-surgical management * Management by any surgery other than breast tumorectomy and axillary sentinel node * Any associated medical, social or psychopathological condition that could compromise the patient's ability to participate in the study * Patient deprived of liberty or under guardianship * Person subject to legal protection or unable to express their consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre François Baclesse
Caen, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Retrospective analysis of pyrotinib in the treatment of HER2-Positive advanced breast cancer previously treated with trastuzumab and pertuzumab
- An equity focused intervention to improve utilization of guideline concordant extended venous thromboembolism prophylaxis after major cancer surgery
- Mind and body: does resilience leave a molecular mark in breast cancer?
- Which pain block works better for breast surgery?
- Can a Triple-Drug combo erase HER2-Positive breast tumors before surgery?
- Bacteria inside tumors may hold the key to breast cancer treatment